Ashish Bhutani
Ashish Bhutani's purchase track record
How the stock did after each of Ashish Bhutani's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/6/2026 | ARES | $1.27M | -1.9% | +7.4% | +11.9% |
| 3/11/2025 | ARES | $1.41M | +18.8% | +24.2% | +16.9% |
| 8/15/2023 | ARES | $981K | +13.5% | +40.3% | +11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Lazard faces lowered price targets from Morgan Stanley and UBS. Morgan Stanley and UBS recently cut their price targets for Lazard to $41 and $40, respectively, while maintaining Underweight and Neutral ratings. This move aligns with broader market concerns about rising bond yields and the firm's high 7.25% dividend yield, which some analysts view as stretched. The stock is currently trading near its support level, reflecting the cautious sentiment from these recent analyst actions.
Transaction History
| ARES | ▲ Buy | Grant | 1,728 | $0 | 7/30/2026 | View on chart |
| ARES | ▲ Buy | Open Market | 10,000 | $1.3M | 2/6/2026 | View on chart |
| ARES | ▲ Buy | Grant | 1,166 | $0 | 7/31/2025 | View on chart |
| ARES | ▲ Buy | Open Market | 10,000 | $1.4M | 3/11/2025 | View on chart |
| ARES | ▲ Buy | Grant | 1,173 | $0 | 8/1/2024 | View on chart |
| ARES | ▲ Buy | Open Market | 10,000 | $981K | 8/15/2023 | View on chart |
| ARES | ▲ Buy | Grant | 1,732 | $0 | 7/27/2023 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 217,937 | — | 3/1/2022 | View on chart |
| LAZ | ▼ Sell | Other | 95,456 | $3.3M | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ares Management Faces UBS Downgrade Amid Energy Stake
UBS maintained a Neutral rating on Ares Management but lowered its price target to $134. This move comes as the firm takes a minority stake in Statera’s 1.9GW flexible energy assets. The stock is currently trading near its 52-week low, reflecting broader market caution despite recent strategic investments.
Ares Management Faces UBS Downgrade Amid Energy Stake. UBS maintained a Neutral rating on Ares Management but lowered its price target to $134. This move comes as the firm takes a minority stake in Statera’s 1.9GW flexible energy assets. The stock is currently trading near its 52-week low, reflecting broader market caution despite recent strategic investments.